Hours

Minutes

Seconds

-40%

on all subscriptions*

Last hours

Enjoy this offer

* See conditions under "Our services"

Encision Inc. is a medical device company. It designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include Product and Service. The Product segment designs, develops, manufactures and markets patented surgical instruments. The Service segment performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause tissue injury that may result in death. The AEM system consists of shielded 5mm AEM Instruments and an AEM monitor. Laparoscopic instruments have the integrated AEM design and include the full range of instruments that are common in laparoscopic surgery. The AEM monitor is compatible with electrosurgical generators.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-06-15	0.001500 $	+114.29%	160

Delayed Quote OTC Markets

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - OTC Markets Other stock markets 12:18:48 2026-06-15 EDT			5-day change	1st Jan Change
0.001500 ^USD	+114.29%		+400.00%	-98.93%

12-12	Encision Inc. Announces Management Changes	CI
12-12	Encision Inc. Announces CEO Changes	CI

Market Cap	2.19M 1.89M 1.74M 1.64M 3.07M 207M 3.1M 20.58M 8.02M 102M 8.24M 8.06M 352M	P/E Ratio 2024	-12.5x	P/E Ratio 2025	-23.9x
Enterprise Value	3.25M 2.8M 2.58M 2.42M 4.55M 307M 4.6M 30.49M 11.88M 151M 12.2M 11.94M 522M	EV / Sales 2024	1.54x	EV / Sales 2025	1.03x
Free-Float	35.96%	Yield 2024 *	-	Yield 2025	-

12-12	Encision Inc. Announces Management Changes	CI
12-12	Encision Inc. Announces CEO Changes	CI
11-13	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-03	Encision Inc. Announces Resignation of Patrick Pace from Its Board of Directors, Effective October 30, 2025	CI
25-08-18	Encision Inc. announced that it has received $0.5 million in funding	CI
25-08-15	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-07-10	Encision Inc. Reports Earnings Results for the Full Year Ended March 31, 2025	CI
25-02-14	Encision Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
24-11-15	Earnings Flash (ECIA) ENCISION Reports Fiscal Q2 Revenue $1.8M	MT
24-11-14	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
24-08-14	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
24-07-15	Earnings Flash (ECIA) ENCISION Reports Q4 Revenue $1.5M	MT
24-07-15	Encision Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

05-04	Encision Inc. Announces Halt of Stock Trading	AQ
04-13	Encision Inc. Announces Fiscal 2026 Fourth Quarter and Full Year Results	AQ
01-29	Encision : Announces Decision to Deregister its Common Stock	PU
24-08-15	Encision : Reports First Quarter Fiscal Year 2025 Results Form 8 K	PU
23-10-23	Encision : Change in Certifying Accountants - Form 8-K	PU

Encision Inc. Stock

Stocks

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

Valuation: Encision Inc.

Chart: Encision Inc.

Latest news : Encision Inc.

Press Releases: Encision Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Encision Inc.

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	+114.29%
1 week	+400.00%
Current month	+650.00%
1 month	-99.25%
3 months	-99.00%
6 months	-99.01%
Current year	-98.93%

1 week	0		0
1 month	0		0.17
Current year	0		0.2
1 year	0		0.4
3 years	0		0.75
5 years	0		1.5
10 years	0		1.5

Manager	Title	Age	Since
Robert Fries CEO	Chief Executive Officer	77	2025-12-07
Brandon Shepard DFI	Director of Finance/CFO	42	2024-07-31
Jason Johnson SAM	Sales & Marketing	51	2022-09-30

Director	Title	Age	Since
Vern Kornelsen BRD	Director/Board Member	93	1990-12-31
Robert Fries BRD	Director/Board Member	77	2024-04-16

Date	Insider	Type	Main position	Quantity	% Market Cap.
04-14	Robert Fries	Buy	Chief Executive Officer	166,785	0.9881%
11-17	Vern Kornelsen	Free	Founder	10,000	0.0592%
11-17	Brian Jackman	Free	VP of Marketing	10,000	0.0592%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ENCISION INC.	+114.29%	+400.00%	-99.53%	-99.62%	25.32K
ABBOTT LABORATORIES	+2.20%	+0.13%	-33.18%	-13.71%	154B
MEDTRONIC PLC	+1.17%	+0.78%	-6.82%	-7.85%	103B
HOYA CORPORATION	+1.63%	+7.06%	+62.45%	+50.82%	55.68B
CENCORA, INC.	+0.01%	+2.69%	-4.76%	+54.74%	54.76B
BECTON, DICKINSON AND COMPANY	-0.25%	-3.22%	-15.71%	-43.33%	40.1B
MEDLINE INC.	-0.64%	+9.73%	-	-	31.57B
DEXCOM, INC.	-1.43%	-4.52%	-10.77%	-44.14%	28.64B
WEST PHARMACEUTICAL SERVICES, INC.	-0.56%	+3.07%	+48.52%	-8.40%	23.41B
TERUMO CORPORATION	-0.76%	-2.82%	-14.91%	-3.18%	20.6B
Average	+11.57%	+41.22%	-8.30%	-12.74%	51.24B
Weighted average by Cap.	+0.88%	+0.51%	-5.66%	-0.76%

	2024	2025
Net sales	6.59M 5.68M 5.23M 4.91M 9.21M 623M 9.31M 61.76M 24.06M 305M 24.72M 24.19M 1.06B	6.56M 5.65M 5.2M 4.88M 9.17M 620M 9.27M 61.47M 23.95M 304M 24.6M 24.08M 1.05B
Net income	-692K -596K -549K -515K -968K -65.4M -978K -6.49M -2.53M -32.03M -2.6M -2.54M -111M	-220K -190K -175K -164K -308K -20.82M -311K -2.06M -804K -10.19M -826K -809K -35.33M
Net Debt	1.29M 1.11M 1.02M 962K 1.81M 122M 1.82M 12.1M 4.72M 59.76M 4.84M 4.74M 207M	1.06M 911K 839K 787K 1.48M 99.91M 1.49M 9.91M 3.86M 48.93M 3.97M 3.88M 170M